North America Syndromic Multiplex Diagnostic Market will grow at a CAGR of 9.0% by 2029

Syndromic multiplex testing is used to diagnose many pathogens simultaneously. In the syndromic multiplex diagnostic, various types of reagents & consumables and instruments & accessories are used, which helps maintain accuracy and provide fast diagnosis results. These multiplex tests are rapidly diagnosed with certain infections, allowing clinical management decisions to be made promptly. The tests based on multiplex technology are known as test panels. The panels used in syndromic testing are designed to diagnose multiple diseases associated with the same or similar syndrome type. These panels help evaluate the cause of the disease at the point of care. Gastrointestinal panels and respiratory panels are the types of syndromic panels.

Syndromic multiplex testing utilizes the advanced technology of multiplex PCR which provides accurate and fast diagnostic results with the help of the multiple panels used in syndromic multiplex diagnostic to provide diagnostic results within an hour. The new generations of syndromic multiplex can rapidly identify the common type of pathogens in the respiratory specimens, blood and cerebrospinal. The use of multiplex panels is associated with quicker turnaround time, reduction of other unnecessary laboratory tests, faster diagnosis and targeted treatment.

Data Bridge Market Research analyses that the North America syndromic multiplex diagnostic market will grow at a CAGR of 9.0% during the forecast period of 2022 to 2029.

Access full Report: https://www.databridgemarketresearch.com/reports/north-america-syndromic-multiplex-diagnostic-market

Drivers

Rise in prevalence of infectious diseases
The rising incidence of infectious bacterial and viral diseases impacts the market's demand because, in the syndromic testing, multiplex real-time PCR technique and the syndromic approach are used for molecular diagnostics of infectious diseases.

Increase in regulatory approval for acute respiratory syndrome coronavirus testing
In May 2020, biomérieux SA received FDA Emergency Use Authorization (EUA) for the BIOFIRE RP2.1 panel, which is used for the detection of 22 pathogens which is causing respiratory infections, including SARS-CoV-2 for COVID-19 disease.

The regulatory authorities, such as the FDA or CE mark, provide Emergency Use Authorization (EUA) approval for commercializing SARS-CoV-2 panels and testing to detect viruses associated with COVID-19 disease, which is a driver for the growth of the market.

Opportunities

Strategic Initiatives taken by market players
In March 2021, F. Hoffman-La Roche Ltd acquired GenMark Diagnostics, a leading multiplex molecular diagnostics provider. This acquisition has helped the company to broaden Roche's molecular diagnostic portfolio. These strategic initiatives taken by the market players, including focused segment product launches, are helping them expand their global reach and enhance their product portfolio and acting as an opportunity for the market's growth.

Introduction of technologically advanced products
The syndromic multiplex testing utilizes the advanced technology of multiplex PCR to detect, isolate, or amplify targeted nucleic acid to provide accurate and fast diagnostic results; the advanced technology provides a diagnostic result within 45 to 60 min. Hence, the development of technologically advanced products is acting as an opportunity for the market's growth.

Restraint/Challenge

High Cost of Diagnostic Products
The multiplex syndromic testing applications utilize the real-time Polymerase chain reaction (PCR), which delivers the results with amplification curves and correct values. The instruments used in the syndromic multiplex diagnostic require high maintenance costs. Hence, the high cost of instruments is a challenge for the market.

GET A PDF SAMPLE: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-syndromic-multiplex-diagnostic-market

Syndromic Multiplex Diagnostic Market Scope
The syndromic multiplex diagnostic market is categorized into five segments: product and services, infection type, disease, panels type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

Reagents & Consumables
Instruments, Software & Accessories
Services
Based on products and services, the North America syndromic multiplex diagnostic market is segmented into reagents & consumables, instruments, software & accessories and services.

Infection Type

Viral
Bacterial
Parasites
Fungal
Based on infection type, the North America syndromic multiplex diagnostic market is segmented into viral, bacterial, parasites and fungal.

Disease

Respiratory Infection
Gastroneteritis
Sexually Transmitted Infections
Sepsis
Meningitis
Others
Based on disease, the North America syndromic multiplex diagnostic market is segmented into respiratory infections, gastroenteritis, sexually transmitted infections, sepsis meningitis and others.

Panels Type

Respiratory Panel
GI-Enteric Panel
Sexually Transmitted Disease Panel
Blood-Sepsis Panel
Meningitis Panel
Others
Based on panels type, the North America syndromic multiplex diagnostic market is segmented into respiratory panel, GI-enteric panel, sexually transmitted disease panel, blood-sepsis panel, meningitis panel and others.

End User

Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Research Institutes
Others

Browse More Reports:

https://dbmrbuisness.blogspot.com/2023/10/structural-heart-imaging-shi-market.html

https://dbmrbuisness.blogspot.com/2023/10/nystagmus-treatment-market-industry.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.